Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-Cycloserine and VRE on iPad for Social Anxiety Disorder
NCT02933684Phase 2Withdrawn
- Sponsor
- Georgia State University
- Start
- Jan 2015
- Primary completion
- Dec 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Social Anxiety Disorder (SAD) comparing DCS Arm with Placebo Arm (2 arms). Primary endpoints: Liebowitz Social Anxiety Scale-Self Report at 17 weeks, Behavioral Avoidance Task at 17 weeks and 1 more. Planned start Jan 2015; status: withdrawn.
02
Drugs
d-cycloserine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT02933684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02933684.